Table 3.
Toxicity
| Adverse Event | Grade 1 or 2 |
Grade 3 or 4 |
||
|---|---|---|---|---|
| No. of Patients | % | No. of Patients | % | |
| CMV reactivation | 9 | 38 | ||
| HSV pneumonia | 1 | 4 | ||
| RSV pneumonia | 1 | 4 | ||
| Parainfluenza pneumonia | 2 | 8 | ||
| Bacterial pneumonia | 3 | 12 | ||
| Sepsis | 4 | 16 | ||
| Urinary tract infection | 1 | 4 | ||
| Epididymitis | 1 | 4 | ||
| Thrombocytopenia | 9 | 37 | ||
| Neutropenia | 11 | 45 | ||
| Anemia | 2 | 8 | ||
| Fever of unknown origin | 4 | 16 | ||
| Hepatic | 3 | 12 | ||
| Renal | 4 | 16 | ||
| Tumor lysis syndrome | 1 | 4 | ||
| Infusion reactions | 9 | 37 | 0 | 0 |
Abbreviations: CMV, cytomegalovirus; HSV, herpes simplex virus; RSV, respiratory syncytial virus.